Yisheng Biopharma (Singapore) Pte. Ltd.
7 clinical trials · Sponsor
◉ Watch Yisheng Biopharma (Singapore) Pte. Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I, the Study to Evaluate the Safety, Immunogenicity and Efficacy of YS-HBV-002 (NCT06162299) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2024-07-01 |
| A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried (NCT05667974) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2023-09-22 |
| A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. (NCT05463419) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2022-10-03 |
| A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals (NCT05305300) | Yisheng Biopharma (Singapore) Pte. Ltd. | 2021-10-18 |
Track Yisheng Biopharma (Singapore) Pte. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.